Published by
Reuters
Reuters
(Reuters) -AstraZeneca’s antibody cocktail against COVID-19 received its first nod for registration in Australia, the country’s medical regulatory body said on Tuesday. The Therapeutic Goods Administration said it granted provisional determination to the Anglo-Swedish drugmaker last week for its antibody cocktail, EVUSHELD, the first protective shot other than vaccines against COVID-19. The regulator said the provisional determination is the first step in the process, adding that it now expects AstraZeneca to submit an application for provisional registration shortly. The determination of the …